NASDAQ NMS - GLOBAL MARKET · IMTX
+10.29% · +$0.8800 · Vol 611.3K
Market closed · last close 4:00 PM ET · price as of 18:41:02 ET
Immatics NV

Immatics NV

Biotechnology
$9.43
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Valuation absence reason unknown · Earnings absence reason unknown
IMTX
Immatics NV
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

55/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is IMTX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading IMTX catalysts
About Immatics NV
Biotechnology
Listed since
2020
Employees
407
Country
DE

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$8.60
Day high
$9.05
Day low
$8.60
Previous close
$8.55
52W high
$11.87
-20.56% from high
52W low
$5.09
64% of range
Market cap
$1.2B
EPS
$-1.7101
Beta
1.02
Shares out
136.7M
Volume
611.3K
1.39× rel vol
Avg volume
438.4K
VWAP
$8.90
Price history computed in-house
1W
+1.95%
1M
+3.85%
3M
-15.73%
1Y
+65.73%
YTD
-10.19%
SMA 50 $9.45 · below
SMA 200 $10.02 · below
52W position 64%

IMTX overview

Veridion Score
55
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around IMTX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading IMTX Form 4 filings
Public disclosures

Congress activity in IMTX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for IMTX in the cached public ledger.

Federal contracts

IMTX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for IMTX in this window.
Lobbying spend

IMTX lobbying filings, year to date.

Registered lobbying filings matched to Immatics NV.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for IMTX in this window.
Loading news for IMTX
Analyst ratings
Sovereign unlock shows live analyst consensus for IMTX.
Options
Sovereign unlock shows live options positioning for IMTX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.